Information  X 
Enter a valid email address

Accrol Group Hldgs (ACRL)

  Print      Mail a friend

Monday 02 November, 2020

Accrol Group Hldgs

COVID-19 Business Update

RNS Number : 8529D
Accrol Group Holdings PLC
02 November 2020

2 November 2020


Accrol Group Holdings plc

("Accrol" or the "Group")




Following the Government's announcement over the weekend that a second lockdown is being initiated from 5 November 2020, Accrol (AIM: ACRL) confirms that, as an essential service provider, it expects to operate normally throughout the lockdown period.


During the first nationwide lockdown in the Spring, Accrol operated at full capacity to supply the heightened consumer demand for its toilet roll and other tissue products and remained fully operational across its three sites, successfully protecting the health and safety of its employees throughout and subsequently through the period of regional restrictions.


The business prepared for a second national lockdown and heightened restrictions and is ready to satisfy additional demand, should it materialise. 


For further information, please contact:




Accrol Group Holdings plc


Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer




Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

Belvedere Communications Limited


Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

[email protected]


Notes to Editors


Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. The business operates from four sites in Lancashire:



A manufacturing, storage, and distribution facility in Blackburn;


A storage and administrative centre in Blackburn;


A facial tissue plant, also in Blackburn; and


A manufacturing, storage, and distribution facility in Leyland.


For more information, please visit .


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t